U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Medical Devices
  3. Medical Device Safety
  4. Emergency Situations (Medical Devices)
  5. Coronavirus (COVID-19) and Medical Devices
  6. Contacts for Medical Devices Related to COVID-19
  1. Coronavirus (COVID-19) and Medical Devices

Contacts for Medical Devices Related to COVID-19

November 8, 2023- The COVID-19 public health emergency (PHE) declared under section 319 of the Public Health Service (PHS) Act expired on May 11, 2023. The COVID-19 enforcement policy guidances within scope of the Transition Plan for Medical Devices That Fall Within Enforcement Policies Issued During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (see List 1) are no longer in effect.

The end of the COVID-19 PHE and certain COVID-19 enforcement policy guidances no longer being in effect do not impact the FDA's ability to authorize devices, including tests, for emergency use. Existing emergency use authorizations (EUAs) for devices relating to COVID-19 remain in effect under section 564 of the Federal Food, Drug, and Cosmetic Act. The FDA encourages manufacturers of devices issued EUAs related to COVID-19 to review the guidance: Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUAs) Related to Coronavirus Disease 2019 (COVID-19), which outlines the FDA's recommendations and expectations to such manufacturers to transition to normal operations when the declarations that allowed for FDA to issue EUAs under section 564 of the Federal Food, Drug, and Cosmetic Act end. Additional information is provided on the page FAQs: What happens to EUAs when a public health emergency ends?

Questions about Emergency Use Authorizations (EUAs)

The FDA has issued EUAs for specific devices for use to diagnose, treat, or prevent COVID-19. The FDA has specific email addresses for questions on, or for submitting, these EUAs.

If you have a question about: Send email to:
EUAs for in vitro diagnostic tests COVID19DX@fda.hhs.gov
EUAs for other devices, including PPE, respirators, ventilators CDRH-NonDiagnosticEUA-Templates@fda.hhs.gov

Enforcement Policy Questions

The FDA has issued enforcement policies for certain devices. Each enforcement policy lists an FDA email address for questions.

If you have a question about the policy on: Send email to:
COVID-19 Tests COVID19DX@fda.hhs.gov
Digital health, particularly digital health devices for psychiatric disorders CDRH-COVID19-DigitalHealthForPsychiatricDisorders@fda.hhs.gov
Gloves CDRH-COVID19-PPE@fda.hhs.gov
Gowns and other apparel CDRH-COVID19-PPE@fda.hhs.gov
Infusion pumps CDRH-COVID19-InfusionPumps@fda.hhs.gov
Masks, including surgical masks CDRH-COVID19-SurgicalMasks@fda.hhs.gov
Ophthalmic devices for remote assessment and monitoring CDRH-COVID19-Ophthalmic@fda.hhs.gov
Respirators, including N95 and KN95 respirators CDRH-COVID19-SurgicalMasks@fda.hhs.gov
Sterilizers, disinfectant devices, and purifiers CDRH-COVID19-SterilizersDisinfectantsPurifiers@fda.hhs.gov
Telethermographic systems, including infrared thermographic systems and thermal imaging cameras CDRH-COVID19-Thermography@fda.hhs.gov
Thermometers, including infrared laser and temple devices CDRH-COVID19-Thermometers@fda.hhs.gov
Ventilators and ventilator accessories CDRH-COVID19-Ventilators@fda.hhs.gov
Viral transport media COVID19Dx@fda.hhs.gov

Other Questions

If you have a question about: Send email to:
Importing PPE, including N95 and KN95 respirators COVID19FDAIMPORTINQUIRIES@fda.hhs.gov
Fraudulent products, such as COVID-19 test kits and at-home test kits FDA-COVID-19-Fraudulent-Products@fda.hhs.gov

All General Questions

Contact the Division of Industry and Consumer Education (DICE).

 

Back to Top